Outlook Therapeutics (OTLK) – Hot Corp. News
-
Outlook Therapeutics (OTLK) Receives FDA Agreement Under SPA for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172M
-
Outlook Therapeutics (OTLK) Upsizes Bought Deal Offering to 40M Shares at $1.25/sh from 8M Shares at $1.25/sh
Back to OTLK Stock Lookup
